TOL — Toleranzia AB Share News
0.000.00%
- SEK126.81m
- SEK121.39m
Brief: Toleranzia Q1 Pretax Loss At SEK 1.3 Million
Brief: Toleranzia Gets A SEK 1 Mln Grant
Brief: Toleranzia Gets Financial Support From Vinnova
Brief: Toleranzia Q4 Pretax Tax Loss Widens To SEK 3.3 Million
Brief: Toleranzia: 3P Is Expected To Deliver GMP Material For Clinical Study During Q4 2021
Brief: Toleranzia Q3 Pre-tax Loss Widens To SEK 1.84 Mln
Brief: Toleranzia Rights Issue Oversubscribed
Brief: Toleranzia April-June Pretax Loss Narrows To SEK 1.3 Mln
Brief: Toleranzia Reports Successfull Cooperation With Testa Center
Brief: EMA Gratns Orphan Drug Designation To Toleranzia Drug Candidate TOL2
Brief: Toleranzia Gets Financing For Cooperation With Testa Center
Brief: Toleranzia Q3 Pretax Loss Widens To SEK 1.2 Million
Brief: Toleranzia April-June Pre-Tax Loss Sek 1.5 Million
Brief: Toleranzia Q1 Operating Loss Slightly Widens To SEK 1.4 Million
Brief: Toleranzia Rights Issue Subscribed To About 94 Percent
Brief: Toleranzia Q4 Pre-Tax Loss At SEK 1.6 Million
Brief: Toleranzia: Rights Issue Of About SEK 24 Million
Brief: Toleranzia Enters Agreement With PX'Therapeutics
Brief: Toleranzia Q2 net loss widens to SEK 1.6 million